(Q37931275)

25 August 2017

1 reference

title

Genetic association studies in drug-induced liver injury (English)

1 reference

25 August 2017

Ann K Daly

1

1 reference

PubMed ID

21913872

25 August 2017

Christopher P Day

series ordinal

2

1 reference

PubMed ID

21913872

25 August 2017

language of work or name

English

0 references

publication date

14 September 2011

1 reference

25 August 2017

Drug Metabolism Reviews

1 reference

25 August 2017

44

1 reference

25 August 2017

116-126

1 reference

25 August 2017

1

1 reference

Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity

25 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Delayed drug hypersensitivity: models of T-cell stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Accuracy of hepatic adverse drug reaction reporting in one English health region

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

A role for the pregnane X receptor in flucloxacillin-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

The natural history of drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

MRP2 haplotypes confer differential susceptibility to toxic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Medical genetics: a marker for Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Pharmacogenetics of the cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

A map of human genome variation from population-scale sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

HLA association of amoxicillin-clavulanate--induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Genetic Polymorphisms in the 5′-Flanking Region Change Transcriptional Regulation of the Human Cytochrome P450IIE1 Gene1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Idiosyncratic drug hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Novel genomic techniques open new avenues in the analysis of monogenic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

HLA-B*5701 screening for hypersensitivity to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

A fresh look at the mechanism of isoniazid-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Co-amoxiclav jaundice: clinical and histological features and HLA class II association.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

An official ATS statement: hepatotoxicity of antituberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Incidence of drug-induced hepatic injuries: a French population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Immunoallergic drug-induced liver injury in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

A study to survey susceptible genetic factors responsible for troglitazone‐associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

Drug Transporter and Metabolizing Enzyme Gene Variants and Nonnucleoside Reverse-Transcriptase Inhibitor Hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2011.605790

10.3109/03602532.2011.605790

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21913872